Successful treatment with low dose Ara-C in de novo acute myeloid leukemia with trilineage myelodysplasia
Kawano, F.; Nishimura, Y.; Tsukamoto, A.; Satoh, M.; Sanada, I.; Shido, T.
International Journal of Hematology 55(1): 101-102
1992
ISSN/ISBN: 0925-5710 PMID: 1581580 Document Number: 393214
Document emailed within 1 workday
Related Documents
Nakayama, S.; Ishikawa, T.; Yabe, H.; Nagai, K.; Kasakura, S.; Uchino, H. 1988: Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3 Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(6): 1026-1030Sennana Sendi, H.; Elghezal, H.; Temmi, H.; Gribaa, M.; Laatiri, A.èn.; Ben Abid, H.él.; Ben Abdeladhime, A.; Elloumi, M.; Hafsia, A.; Saad, A. 2002: Prognostic impact of karyotype in de novo acute myeloid leukemia: study of 139 cases La Tunisie Medicale 80(9): 531-535
Niparuck, P.; Chuncharunee, S.; Ungkanont, A.; Udomtrupayakul, U.; Aungchaisuksiri, P.; Rerkamnuatchoke, B.; Jootar, S.; Atichartakarn, V. 2009: Long-term outcomes of de novo acute myeloid leukemia in Thai patients Journal of the Medical Association of Thailand 92(9): 1143-1149
Schoch, C.; Kern, W.; Schnittger, S.; Büchner, T.; Hiddemann, W.; Haferlach, T. 2004: The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups Haematologica 89(9): 1082-1090
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Unal, S.; Cakir, M.; Kuşkonmaz, B.ş; Cetin, M.; Tuncer, A.M. 2009: Successful treatment with gemtuzumab ozogamicin monotherapy in a pediatric patient with resistant relapse of acute myeloid leukemia Turkish Journal of Pediatrics 51(1): 69-71
Ozdemir, H.; Ciftçi, E.; Karbuz, A.; Oktay, G.ül.şa.; Aysev, D.; Yavuz, G.ül.; Ince, E. 2012: Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child Turkish Journal of Pediatrics 54(1): 59-60
Musso, M.; Porretto, F.; Crescimanno, A.; Bondì, F.; Polizzi, V.; Scalone, R.; Tolomeo, M.; Mariani, G. 1997: Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia Haematologica 82(5 Suppl): 4-8
Gritsaev, S.V.; Martynkevich, I.S.; Chubukina, Z.V.; Petrova, E.V.; Kostroma, I.I.; Ivanova, M.P.; Martynenko, L.S.; Potikhonova, N.A.; Bubnova, L.N.; Abdulkadyrov, K.M. 2014: The specific features of the immunophenotype of blast cells in patients with de novo normal karyotype acute myeloid leukemia and FLT3-ITD mutation Terapevticheskii Arkhiv 86(3): 71-77
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109
Luikart, S.D.; Fosdick, L.; Ogle, K.M.; Peterson, B.A.; Bloomfield, C.D. 1989: Serum and urine glycosaminoglycans in myeloid leukemia and myelodysplasia Leukemia 3(1): 48-50
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Hirase, C.; Matsumura, I. 2012: Treatment for de novo chronic myeloid leukemia in chronic phase Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 298-303
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Cheson, B.D. 1990: Clinical trials referral resource. High-dose chemo for acute myeloid leukemia Oncology 4(7): 69-70; 72-4; 77-78 Passim
Sharkunov, N.N.; Moiseyeva, T.N.; Zybunova, E.E.; Vinogradova, O.Y.; Kravchenko, S.K. 2012: Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia Terapevticheskii Arkhiv 84(11): 71-74
Sutoh, H.; Yamauchi, T.; Gotoh, N.; Sugiyama, M.; Ueda, T. 2003: Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia Anticancer Research 23(6d): 5037-5042
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Bassan, R.; Lerede, T.; Buelli, M.; Borleri, G.; Bellavita, P.; Rambaldi, A.; Barbui, T. 1998: A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia Haematologica 83(5): 422-427
Hines, J.D.; Mazza, J.J.; Oken, M.M.; Bennett, J.M.; Adelstein, D.J.; Keller, A.; O'Connell, M.J. 1985: High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase i Pilot Study for the Eastern Cooperative Oncology Group Seminars in Oncology 12(2 Suppl 3: 117-119